Clinical trial
Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study
NCT01862861 is registered in ClinicalTrials.gov with Medimix Specialty Pharmacy, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study
- Lead sponsor
- Medimix Specialty Pharmacy, LLC
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- July 31, 2013
- Enrollment
- 69 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
menopause